GC Corp.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
GC Biopharma and Novelty Nobility Enter into Joint Research and Development Agreement for Geographic Atrophy Therapies 2024-10-29 09:13
GC Biopharma and Hanmi Pharmaceutical Receives IND Clearance for Phase 1/2 Clinical Trial from the U.S. FDA 2024-09-03 15:59
GCCL Completes Proactive Development of Biosimilar Clinical Trial Analysis Methods, Providing Customized Analysis Services through Enhanced R&D Capabilities 2024-07-17 10:38
FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A 2024-06-10 16:18
GC Genome Highlights Promising New Approach for Non-invasive Colorectal Cancer Detection at ASCO 2024 2024-06-05 14:00
GCBP Sponsors 2024 Spring Symposium for KASBP and Present Research Findings 2024-06-04 13:00
GCCL Leverages ddPCR to Enhance Gene/cell Therapy Clinical Trial Services 2024-05-22 13:00
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Clearance 2024-05-21 15:12
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Approval 2024-05-20 14:07
GC Genome to Present New Clinical Data on Colorectal Cancer Detection at the ASCO Annual Meeting 2024 2024-05-07 13:27
GC Genome to Present New Data at AACR 2024 2024-03-25 21:00
GC Biopharma Presents Updates on its LSD Treatments at the WORLDSymposium 2024 2024-02-14 16:33
European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma's Treatment for Sanfilippo Syndrome (Type A) 2024-01-23 11:53
GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI) 2023-12-18 09:49
GC Biopharma's groundbreaking for the plasma fractionation plant in Indonesia 2023-12-06 08:56
GC Biopharma establishes mRNA production facility in Hwasun, Korea 2023-12-01 16:31
GCCL Wins Top 10 Bioanalytical Services Providers in APAC 2023 2023-11-20 14:39
GC Genome Enters License Agreement with MP Group 2023-11-10 13:00
The World's First "Recombinant Anthrax Vaccine": GC Biopharma applies for MFDS Approval 2023-11-06 09:11
GC Cell Joins U.S Cancer Moonshot Project 2023-10-25 11:27
1 2 3 4